Lisa M. Kopcho - Concepedia

Author

Lisa M. Kopcho

Bristol-Myers Squibb (United States)

Also Known As

Kopcho, Lisa, Lisa Kopcho, Lisa M Kopcho, Lisa M. Kopcho

Publications

809

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Wilmington University DuPont (United States)Biocon (India)Bristol-Myers Squibb (India)

About

Lisa M. Kopcho is an author at Bristol-Myers Squibb (United States) specializing in biochemistry, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	10	10	360
2	Natural Sciences	8	8	275
3	Medicine	7	7	195
4	Health Sciences	1	1	36
5	Biomolecular Engineering	1	1	33

Lisa M. Kopcho

Publications

758

Citations

H-Index

Page 1

	Year	Citations
Mechanism of Gly-Pro-pNA cleavage catalyzed by dipeptidyl peptidase-IV and its inhibition by saxagliptin (BMS-477118) Young B. Kim, Lisa M. Kopcho, Mark Kirby, Archives of Biochemistry and Biophysics Chemical BiologyBiochemistryNatural SciencesPeptoidMolecular Biology	2005	72
Helicobacter pylori-selective Antibacterials Based on Inhibition of Pyrimidine Biosynthesis Robert A. Copeland, Jovita Marcinkeviciene, Tasir S. Haque, Journal of Biological Chemistry	2000	68
Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor Aiying Wang, Charles R. Dorso, Lisa M. Kopcho, BMC Pharmacology	2012	59
Parallel Synthesis of Potent, Pyrazole-Based Inhibitors of <i>Helicobacter </i><i>p</i><i>ylori</i> Dihydroorotate Dehydrogenase Tasir S. Haque, Seifu Tadesse, Jovita Marcinkeviciene, Journal of Medicinal Chemistry Helicobacter Pylori DhodaseParallel SynthesisPyrazole-based InhibitorsChemical BiologyPharmaceutical Chemistry	2002	57
Selective inhibition of bacterial dihydroorotate dehydrogenases by thiadiazolidinediones Jovita Marcinkeviciene, Michael J. Rogers, Lisa M. Kopcho, Biochemical Pharmacology Enzymatic ModificationAlcohol DehydrogenasesBacterial Dihydroorotate DehydrogenasesBiochemistry	2000	52
P-Glycoprotein Efflux and Other Factors Limit Brain Amyloid β Reduction by β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitors in Mice Jere E. Meredith, Lorin A. Thompson, Jeremy H. Toyn, Journal of Pharmacology and Experimental Therapeutics	2008	41
Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches Hai‐Yun Xiao, Ning Li, James J.‐W. Duan, Journal of Medicinal Chemistry	2020	39
Synthesis and SAR of indole-and 7-azaindole-1,3-dicarboxamide hydroxyethylamine inhibitors of BACE-1 Lawrence R. Marcin, Mendi A. Higgins, F. Christopher Zusi, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesPharmacotherapy	2010	37
MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity Dong Cheng, Bradley A. Zinker, Yi Luo, Cell Metabolism ObesityInflammationMetabolic SyndromeLiver FibrosisMetabolic Disorder	2022	36
Characterization of Recombinant, Soluble β-Secretase from an Insect Cell Expression System William D. Mallender, Debra Yager, Luisa Onstead, Molecular Pharmacology	2001	35

Page 1